Medical Device Import for Clinical Trial Deployment in Kenya
Engineering Case Study
Case Study 2: Medical Device Import for Clinical Trial Deployment in Kenya
Scenario
A Boston-based medtech startup is deploying 85 portable ultrasound probes to Nairobi for a Phase II clinical trial across three county hospitals. The devices are manufactured in Germany and shipped under DAP (Delivered at Place) Incoterm. Constraints include: (1) Kenya Revenue Authority (KRA) mandates full payment of import duties and VAT before release—even for humanitarian/clinical use; (2) no duty exemptions apply without prior KRA approval (not granted in time); (3) exchange rate volatility (USD–KES) requires all cost modeling in USD to prevent budget slippage; and (4) handling includes mandatory KEBS (Kenya Bureau of Standards) conformity assessment—charged per unit but aggregated in the handling_cost input.
Given Data
- Purchase Unit Cost: $210.00 USD
- Freight Cost: $4,270 USD (air freight + fuel surcharge + security screening)
- Insurance Cost: $225 USD (0.12% of $188,700 declared value)
- Handling Cost: $1,980 USD (KEBS testing: $18/unit × 85 units + port storage + documentation)
- Duty Cost: $2,120 USD (25% duty on CIF value: ($210 × 85) + $4,270 + $225 = $22,145 → 25% = $5,536.25 — but KRA applied a statutory ceiling of $2,120 due to medical device tariff subheading 9018.00.10)
- Quantity of Units: 85 units
Calculation
Total Landed Cost = (Purchase Unit Cost × Quantity) + Freight Cost + Insurance Cost + Handling Cost + Duty Cost
= ($210.00 × 85) + $4,270 + $225 + $1,980 + $2,120
= $17,850 + $4,270 + $225 + $1,980 + $2,120
= $26,445
Total Landed Cost per Unit = Total Landed Cost ÷ Quantity of Units
= $26,445 ÷ 85
= $311.12 USD/unit (rounded to two decimals)
Result and Decision
At $311.12/unit, the landed cost exceeded the trial’s allocated $295/unit cap by $16.12/unit ($1,370 total). Rather than delay the trial, the team renegotiated air freight terms with their forwarder (securing $680 reduction) and submitted an expedited KRA waiver request citing WHO Essential Medicines List inclusion—approved 3 days pre-arrival, reducing duty to $0. Revised landed cost became $303.24/unit, still over cap—but acceptable given trial timeline sensitivity. Final approval was granted with finance sign-off for a one-time variance.
Lesson
Always validate tariff subheadings and statutory ceilings with destination-country revenue authorities during procurement planning—not post-shipment—as published rates often differ materially from nominal duty percentages due to regulatory caps or subheading-specific provisions.